These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
91 related articles for article (PubMed ID: 110933)
1. Synthesis and pharmacological evaluation of cis-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-1-ones. Tricyclic analogues related to the antilipidemic drug clofibrate. Witiak DT; Loh W; Feller DR; Baldwin JR; Newman HA; Sober CL; Cavestri RC J Med Chem; 1979 Jun; 22(6):699-705. PubMed ID: 110933 [TBL] [Abstract][Full Text] [Related]
2. Diethyl (4baalpha,4calpha,9aalpha,9balpha)-3,6-dichlorocyclobuta[1,2-b:3,4-b']bisbenzofuran-9a,9b(4bH,4cH)-dicarboxylate: the cis,syn photodimer of ethyl 5-chlorobenzofuran-2-carboxylate, an analogue related to the antilipidemic drug clofibrate. Witiak DT; Newman HA; Poochikian GK; Fogt SW; Baldwin JR; Sober CL; Feller DR J Med Chem; 1978 Aug; 21(8):833-7. PubMed ID: 99517 [TBL] [Abstract][Full Text] [Related]
3. Synthesis and antilipidemic properties of cis-7-chloro-3a, 8b-dihydro-3a-methylfuro[3,4-b]benzofuran-3(1H)-one, a tricyclic clofibrate related lactone having a structural resemblance to mevalonolactone. Witiak DT; Kuwano E; Feller DR; Baldwin JR; Newman HA; Sankrappa SK J Med Chem; 1976 Oct; 19(10):1214-20. PubMed ID: 994152 [TBL] [Abstract][Full Text] [Related]
4. Synthesis and pharmacological evaluation of a clofibrate-related tricyclic spirolactone, 5-chloro-4',5-dihydrospiro[benzofuran-2(3H),3'(2'H)-furan]-2'-one. Witiak DT; Cavestri RC; Newman HA; Baldwin JR; Sober CL; Feller DR J Med Chem; 1978 Dec; 21(12):1198-202. PubMed ID: 722728 [TBL] [Abstract][Full Text] [Related]
5. 9-Chloro-2,3-dihydro-5H-1,4-dioxepino(6,5-b)benzofuran, a novel antilipidemic agent structurally related to clofibrate. Witiak DT; Poochikian GK; Feller DR; Kenfield NA; Newman HA J Med Chem; 1975 Oct; 18(10):992-6. PubMed ID: 1159693 [TBL] [Abstract][Full Text] [Related]
6. Antilipidemic activity of 4-oxo-functionalized ethyl 6-chlorochroman-2-carboxylate analogs and a related tricyclic lactone in three rat models. Cavestri RC; Minatelli JA; Baldwin JR; Loh W; Feller DR; Newman HA; Sober CL; Witiak DT Lipids; 1981 Jan; 16(1):30-6. PubMed ID: 7219078 [TBL] [Abstract][Full Text] [Related]
7. Mode of action of the lipid-lowering agents, clofibrate and BM 15075, on cholesterol biosynthesis in rat liver. Berndt J; Gaumert R; Still J Atherosclerosis; 1978 Jun; 30(2):147-52. PubMed ID: 678316 [TBL] [Abstract][Full Text] [Related]
8. Comparative antilipidemic effects of various ethyl 5-substituted benzofuran-, 2,3-dihydrobenzofuran-, and 3(2H)-benzofuranone-2-carboxylate analogs of clofibrate in a triton hyperlipidemic rat model. Witiak DT; Newman HA; Poochikian GK; Loh W; Sankarappa SK Lipids; 1976 May; 11(5):384-91. PubMed ID: 1271976 [TBL] [Abstract][Full Text] [Related]
9. Anticholesterolemic effect of 3,4-di(OH)-phenylpropionic amides in high-cholesterol fed rats. Kim SJ; Bok SH; Lee S; Kim HJ; Lee MK; Park YB; Choi MS Toxicol Appl Pharmacol; 2005 Oct; 208(1):29-36. PubMed ID: 16164959 [TBL] [Abstract][Full Text] [Related]
10. Comparison of hypocholesterolemic activity for cyclic analogs of clofibrate in normolipemic rats. Goldberg AP; Mellon WS; Witiak DT; Feller DR Atherosclerosis; 1977 May; 27(1):15-25. PubMed ID: 857813 [TBL] [Abstract][Full Text] [Related]
11. Synthesis of arylnaphthalenyl derivatives: inhibitors of 3-hydroxy-3-methylglutaryl-coenzyme a reductase. Mewshaw RE; Hild EK; Commons TJ; Strike DP Drug Des Deliv; 1988 Nov; 3(3):235-43. PubMed ID: 3255330 [TBL] [Abstract][Full Text] [Related]
12. Effect of clofibrate on fatty acid desaturation of rats treated with ethanol. Peluffo RO; Nervi AM; Brenner RR Acta Physiol Lat Am; 1981; 31(2):119-28. PubMed ID: 6821269 [TBL] [Abstract][Full Text] [Related]
13. Dolichol biosynthesis in rat liver peroxisomes. Appelkvist EL Acta Chem Scand B; 1987 Jan; 41(1):73-5. PubMed ID: 3107291 [No Abstract] [Full Text] [Related]
14. Pharmacologic effects of 4-chlorophenol in rats: comparison to clofibrate. Phornchirasilp S; Patel ST; Hanson JM; Newman HA; Witiak DT; Feller DR Proc Soc Exp Biol Med; 1989 Jun; 191(2):139-46. PubMed ID: 2726779 [TBL] [Abstract][Full Text] [Related]
15. Synthesis and biological activity of new HMG-CoA reductase inhibitors. 3. Lactones of 6-phenoxy-3,5-dihydroxyhexanoic acids. Jendralla H; Granzer E; von Kerekjarto B; Krause R; Schacht U; Baader E; Bartmann W; Beck G; Bergmann A; Kesseler K J Med Chem; 1991 Oct; 34(10):2962-83. PubMed ID: 1656041 [TBL] [Abstract][Full Text] [Related]
16. Sex difference in N-demethylation activity of ethylmorphine in rat liver microsomes. Kitada M; Omori S; Igarashi T; Kanakubo Y; Kitagawa H Biochem Biophys Res Commun; 1980 Dec; 97(4):1527-34. PubMed ID: 6783038 [No Abstract] [Full Text] [Related]
17. Influence of the oral contraceptive, menstranol, on drug-metabolizing enzymes of female rats in thiamin-supplemented and deficiency states. Wade AE; Evans JL; Seitz A Pharmacology; 1976; 14(2):104-14. PubMed ID: 822434 [TBL] [Abstract][Full Text] [Related]
18. Influence of norethindrone on drug-metabolizing enzymes of female rat liver in various B-vitamin deficiency states. Wade AE; Evans JS Pharmacology; 1977; 15(4):289-301. PubMed ID: 408827 [TBL] [Abstract][Full Text] [Related]
19. Kinetics of ethylmorphine N-demethylase at low substrate concentrations and its implications concerning the role of the stimulation of NADPH-cytochrome P-450 reductase activity in mixed-function oxidase activity. Thompson JA; Holtzman JL Biochem Pharmacol; 1977 Oct; 26(19):1803-7. PubMed ID: 410419 [No Abstract] [Full Text] [Related]